BlackRock’s Scribe Therapeutics SCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SCTX
BBA
BlackRock's SCTX Position: Q3 2026 in Review
BlackRock opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 679,786 shares worth $12.5M. The stake represents ﹤0.01% of the portfolio and ranks #3543 among its holdings.
62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.
- BlackRock held 679,786 shares of Scribe Therapeutics worth $12.5M as of Q3 2026.
- Scribe Therapeutics was a new BlackRock position in Q3 2026.
- Scribe Therapeutics made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #3543 holding.
- 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.
Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.